[1]
R. Rana, S. Das, A. Swami, D. Pon, S. Ramesh, and S. D. Kumar, “Strategic therapeutic approaches to overcome emerging dual SRC/ABL kinase inhibitors resistances in chronic phase Ph positive chronic myeloid leukemia”, Asian J Med Sci, vol. 6, no. 1, pp. 8–15, Jul. 2014, doi: 10.3126/ajms.v6i1.10454.